Molecular mechanisms of transcription and replication of the influenza A virus genome

Abstract

Influenza A virus is one of the major pathogens that pose a large threat to human health worldwide and has caused pandemics. Influenza A virus is the Orthomyxoviridae prototype, and has 8 segmented negative-sense single-stranded RNA (vRNA) as its genome. Influenza virus RNA polymerase (RdRp) consists of three subunits PB2, PB1 and PA, and catalyzes both transcription and replication. Recently, intensive biochemical and structural analysis of its RdRp has been performed. In this paper, we review the details from the biochemical analysis of the purified influenza virus RdRp and the classical ribonucleoprotein complex, as well as piece together their structures to form an overall picture.

Keywords

influenza virus / RNA polymerase / ribonucleoprotein complex / transcription / replication

References

[1] Almond J W (1977). A single gene determines the host range of influenza virus. Nature, 270(5638): 617–618

[2] Area E, Martín-Benito J, Gastaminza P, Torreira E, Valpuesta J M, Carrascosa J L, Ortín J (2004). 3D structure of the influenza virus polymerase complex: localization of subunit domains. Proc Natl Acad Sci USA, 101(1): 308–313

[3] Argos P (1988). A sequence motif in many polymerases. Nucleic Acids Res, 16(21): 9909–9916

[4] Ball L A (2007 ). Virus replication strategies, 5th ed. Lippincott Williams & Wilkins

[5] Baudin F, Bach C, Cusack S, Ruigrok R W (1994). Structure of influenza virus RNP. I. Influenza virus nucleoprotein melts secondary structure in panhandle RNA and exposes the bases to the solvent. EMBO J, 13(13): 3158–3165

[6] Beaton A R, Krug R M (1981). Selected host cell capped RNA fragments prime influenza viral RNA transcription in vivo. Nucleic Acids Res, 9(17): 4423–4436

[7] Beaton A R, Krug R M (1986). Transcription antitermination during influenza viral template RNA synthesis requires the nucleocapsid protein and the absence of a 5′ capped end. Proc Natl Acad Sci USA, 83(17): 6282–6286

[8] Beigel J, Bray M (2008). Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res, 78(1): 91–102

[9] Biswas S K, Nayak D P (1994). Mutational analysis of the conserved motifs of influenza A virus polymerase basic protein 1. J Virol, 68(3): 1819–1826

[10] Blaas D, Patzelt E, Kuechler E (1982a). Cap-recognizing protein of influenza virus. Virology, 116(1): 339–348

[11] Blaas D, Patzelt E, Kuechler E (1982b). Identification of the cap binding protein of influenza virus. Nucleic Acids Res, 10(15): 4803–4812

[12] Bouloy M, Plotch S J, Krug R M (1978). Globin mRNAs are primers for the transcription of influenza viral RNA in vitro. Proc Natl Acad Sci USA, 75(10): 4886–4890

[13] Bouloy M, Plotch S J, Krug R M (1980). Both the 7-methyl and the 2′-O-methyl groups in the cap of mRNA strongly influence its ability to act as primer for influenza virus RNA transcription. Proc Natl Acad Sci USA, 77(7): 3952–3956

[14] Bullido R, Gómez-Puertas P, Albo C, Portela A (2000). Several protein regions contribute to determine the nuclear and cytoplasmic localization of the influenza A virus nucleoprotein. J Gen Virol, 81(Pt 1): 135–142

[15] Chan A Y, Vreede F T, Smith M, Engelhardt O G, Fodor E (2006). Influenza virus inhibits RNA polymerase II elongation. Virology, 351(1): 210–217

[16] Chen G W, Chang S C, Mok C K, Lo Y L, Kung Y N, Huang J H, Shih Y H, Wang J Y, Chiang C, Chen C J, Shih S R (2006). Genomic signatures of human versus avian influenza A viruses. Emerg Infect Dis, 12(9): 1353–1360

[17] Chung T D, Cianci C, Hagen M, Terry B, Matthews J T, Krystal M, Colonno R J (1994). Biochemical studies on capped RNA primers identify a class of oligonucleotide inhibitors of the influenza virus RNA polymerase. Proc Natl Acad Sci USA, 91(6): 2372–2376

[18] Coloma R, Valpuesta J M, Arranz R, Carrascosa J L, Ortín J, Martín-Benito J (2009). The structure of a biologically active influenza virus ribonucleoprotein complex. PLoS Pathog, 5(6): e1000491

[19] Crépin T, Dias A, Palencia A, Swale C, Cusack S, Ruigrok R W (2010). Mutational and metal binding analysis of the endonuclease domain of the influenza virus polymerase PA subunit. J Virol, 84(18): 9096–9104

[20] Cros J F, García-Sastre A, Palese P (2005). An unconventional NLS is critical for the nuclear import of the influenza A virus nucleoprotein and ribonucleoprotein. Traffic, 6(3): 205–213

[22] Deng T, Sharps J, Fodor E, Brownlee G G (2005). In vitro assembly of PB2 with a PB1-PA dimer supports a new model of assembly of influenza A virus polymerase subunits into a functional trimeric complex. J Virol, 79(13): 8669–8674

[21] Deng T, Engelhardt O G, Thomas B, Akoulitchev A V, Brownlee G G, Fodor E (2006a). Role of ran binding protein 5 in nuclear import and assembly of the influenza virus RNA polymerase complex. J Virol, 80(24): 11911–11919

[23] Deng T, Sharps J L, Brownlee G G (2006b). Role of the influenza virus heterotrimeric RNA polymerase complex in the initiation of replication. J Gen Virol, 87(Pt 11): 3373–3377

[24] Deng T, Vreede F T, Brownlee G G (2006c). Different de novo initiation strategies are used by influenza virus RNA polymerase on its cRNA and viral RNA promoters during viral RNA replication. J Virol, 80(5): 2337–2348

[25] Deyde V M, Xu X, Bright R A, Shaw M, Smith C B, Zhang Y, Shu Y, Gubareva L V, Cox N J, Klimov A I (2007). Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis, 196(2): 249–257

[26] Dias A, Bouvier D, Crépin T, McCarthy A A, Hart D J, Baudin F, Cusack S, Ruigrok R W (2009). The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature, 458(7240): 914–918

[27] Duan S, Boltz D A, Seiler P, Li J, Bragstad K, Nielsen L P, Webby R J, Webster R G, Govorkova E A (2010). Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets. PLoS Pathog, 6(7): e1001022

[28] Duijsings D, Kormelink R, Goldbach R (2001). In vivo analysis of the TSWV cap-snatching mechanism: single base complementarity and primer length requirements. EMBO J, 20(10): 2545–2552

[29] Engelhardt O G, Smith M, Fodor E (2005). Association of the influenza A virus RNA-dependent RNA polymerase with cellular RNA polymerase II. J Virol, 79(9): 5812–5818

[30] Fechter P, Mingay L, Sharps J, Chambers A, Fodor E, Brownlee G G (2003). Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding. J Biol Chem, 278(22): 20381–20388

[31] Flick R, Hobom G (1999). Interaction of influenza virus polymerase with viral RNA in the ‘corkscrew’ conformation. J Gen Virol, 80(Pt 10): 2565–2572

[32] Fodor E, Brownlee G (2002). Influenza virus replication. In: Potter C, ed. Influenza. Elsevier, Amsterdom, pp. 1–29

[33] Fodor E, Mikulasova A, Mingay L J, Poon L L, Brownlee G G (2000). Messenger RNAs that are not synthesized by RNA polymerase II can be 3′ end cleaved and polyadenylated. EMBO Rep, 1(6): 513–518

[34] Fodor E, Palese P, Brownlee G G, García-Sastre A (1998). Attenuation of influenza A virus mRNA levels by promoter mutations. J Virol, 72(8): 6283–6290

[35] Fodor E, Pritlove D C, Brownlee G G (1994). The influenza virus panhandle is involved in the initiation of transcription. J Virol, 68(6): 4092–4096

[36] Fodor E, Smith M (2004). The PA subunit is required for efficient nuclear accumulation of the PB1 subunit of the influenza A virus RNA polymerase complex. J Virol, 78(17): 9144–9153

[37] Furuta Y, Takahashi K, Fukuda Y, Kuno M, Kamiyama T, Kozaki K, Nomura N, Egawa H, Minami S, Watanabe Y, Narita H, Shiraki K (2002). In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob Agents Chemother, 46(4): 977–981

[38] Furuta Y, Takahashi K, Kuno-Maekawa M, Sangawa H, Uehara S, Kozaki K, Nomura N, Egawa H, Shiraki K (2005). Mechanism of action of T-705 against influenza virus. Antimicrob Agents Chemother, 49(3): 981–986

[39] Gabriel G, Dauber B, Wolff T, Planz O, Klenk H D, Stech J (2005). The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci USA, 102(51): 18590–18595

[40] Gabriel G, Herwig A, Klenk H D (2008). Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus. PLoS Pathog, 4(2): e11

[41] Garcin D, Kolakofsky D (1992). Tacaribe arenavirus RNA synthesis in vitro is primer dependent and suggests an unusual model for the initiation of genome replication. J Virol, 66(3): 1370–1376

[42] Garcin D, Lezzi M, Dobbs M, Elliott R M, Schmaljohn C, Kang C Y, Kolakofsky D (1995). The 5′ ends of Hantaan virus (Bunyaviridae) RNAs suggest a prime-and-realign mechanism for the initiation of RNA synthesis. J Virol, 69(9): 5754–5762

[43] González S, Zürcher T, Ortín J (1996). Identification of two separate domains in the influenza virus PB1 protein involved in the interaction with the PB2 and PA subunits: a model for the viral RNA polymerase structure. Nucleic Acids Res, 24(22): 4456–4463

[44] Guilligay D, Tarendeau F, Resa-Infante P, Coloma R, Crepin T, Sehr P, Lewis J, Ruigrok R W, Ortin J, Hart D J, Cusack S (2008). The structural basis for cap binding by influenza virus polymerase subunit PB2. Nat Struct Mol Biol, 15(5): 500–506

[45] Gutiérrez R A, Naughtin M J, Horm S V, San S, Buchy P (2009). A(H5N1) virus evolution in South East Asia. Viruses, 1(3): 335–361

[46] Hagen M, Chung T D, Butcher J A, Krystal M (1994). Recombinant influenza virus polymerase: requirement of both 5′ and 3′ viral ends for endonuclease activity. J Virol, 68(3): 1509–1515

[47] Hankins R W, Nagata K, Bucher D J, Popple S, Ishihama A (1989). Monoclonal antibody analysis of influenza virus matrix protein epitopes involved in transcription inhibition. Virus Genes, 3(2): 111–126

[48] Hao L, Sakurai A, Watanabe T, Sorensen E, Nidom C A, Newton M A, Ahlquist P, Kawaoka Y (2008). Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature, 454(7206): 890–893

[49] Hatta M, Gao P, Halfmann P, Kawaoka Y (2001). Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science, 293(5536): 1840–1842

[50] Hauge S H, Dudman S, Borgen K, Lackenby A, Hungnes O (2009). Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg Infect Dis, 15: 155–162

[51] Hayden F (2009). Developing new antiviral agents for influenza treatment: what does the future hold? Clin Infect Dis, 48(Suppl 1): S3–S13

[52] He X, Zhou J, Bartlam M, Zhang R, Ma J, Lou Z, Li X, Li J, Joachimiak A, Zeng Z, Ge R, Rao Z, Liu Y (2008). Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus. Nature, 454(7208): 1123–1126

[53] Herfst S, Chutinimitkul S, Ye J, de Wit E, Munster V J, Schrauwen E J, Bestebroer T M, Jonges M, Meijer A, Koopmans M, Rimmelzwaan G F, Osterhaus A D, Perez D R, Fouchier R A (2010). Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission. J Virol, 84(8): 3752–3758

[54] Honda A, Endo A, Mizumoto K, Ishihama A (2001). Differential roles of viral RNA and cRNA in functional modulation of the influenza virus RNA polymerase. J Biol Chem, 276(33): 31179–31185

[55] Honda A, Mizumoto K, Ishihama A (1999). Two separate sequences of PB2 subunit constitute the RNA cap-binding site of influenza virus RNA polymerase. Genes Cells, 4(8): 475–485

[56] Honda A, Mizumoto K, Ishihama A (2002). Minimum molecular architectures for transcription and replication of the influenza virus. Proc Natl Acad Sci USA, 99(20): 13166–13171

[57] Honda A, Mukaigawa J, Yokoiyama A, Kato A, Ueda S, Nagata K, Krystal M, Nayak D P, Ishihama A (1990). Purification and molecular structure of RNA polymerase from influenza virus A/PR8. J Biochem, 107(4): 624–628

[58] Honda A, Okamoto T, Ishihama A (2007). Host factor Ebp1: selective inhibitor of influenza virus transcriptase. Genes Cells, 12(2): 133–142

[59] Honda A, Uéda K, Nagata K, Ishihama A (1988). RNA polymerase of influenza virus: role of NP in RNA chain elongation. J Biochem, 104(6): 1021–1026

[60] Huarte M, Sanz-Ezquerro J J, Roncal F, Ortín J, Nieto A (2001). PA subunit from influenza virus polymerase complex interacts with a cellular protein with homology to a family of transcriptional activators. J Virol, 75(18): 8597–8604

[61] Huiet L, Feldstein P A, Tsai J H, Falk B W (1993). The maize stripe virus major noncapsid protein messenger RNA transcripts contain heterogeneous leader sequences at their 5′ termini. Virology, 197(2): 808–812

[62] Hurt A C, Ho H T, Barr I (2006). Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors. Expert Rev Anti Infect Ther, 4(5): 795–805

[63] Ishihama A, Nagata K (1988). Viral RNA polymerases. CRC Crit Rev Biochem, 23(1): 27–76

[64] Jiang H, Zhang S, Wang Q, Wang J, Geng L, Toyoda T (2010). Influenza virus genome C4 promoter/origin attenuates its transcription and replication activity by the low polymerase recognition activity. Virology, 408(2): 190–196

[65] Jin H, Elliott R M (1993a). Characterization of Bunyamwera virus S RNA that is transcribed and replicated by the L protein expressed from recombinant vaccinia virus. J Virol, 67(3): 1396–1404

[66] Jin H, Elliott R M (1993b). Non-viral sequences at the 5′ ends of Dugbe nairovirus S mRNAs. J Gen Virol, 74(Pt 10): 2293–2297

[67] Kao C C, Singh P, Ecker D J (2001). De novo initiation of viral RNA-dependent RNA synthesis. Virology, 287(2): 251–260

[68] Kao C C, Sun J H (1996). Initiation of minus-strand RNA synthesis by the brome mosaicvirus RNA-dependent RNA polymerase: use of oligoribonucleotide primers. J Virol, 70(10): 6826–6830

[69] Kao R Y, Yang D, Lau L S, Tsui W H, Hu L, Dai J, Chan M P, Chan C M, Wang P, Zheng B J, Sun J, Huang J D, Madar J, Chen G, Chen H, Guan Y, Yuen K Y (2010). Identification of influenza A nucleoprotein as an antiviral target. Nat Biotechnol, 28(6): 600–605

[70] Karlas A, Machuy N, Shin Y, Pleissner K P, Artarini A, Heuer D, Becker D, Khalil H, Ogilvie L A, Hess S, Mäurer A P, Müller E, Wolff T, Rudel T, Meyer T F (2010). Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature, 463(7282): 818–822

[71] Kashiwagi T, Leung B W, Deng T, Chen H, Brownlee G G (2009). The N-terminal region of the PA subunit of the RNA polymerase of influenza A/HongKong/156/97 (H5N1) influences promoter binding. PLoS One, 4(5): e5473

[72] Kawaguchi A, Nagata K (2007). De novo replication of the influenza virus RNA genome is regulated by DNA replicative helicase, MCM. EMBO J, 26(21): 4566–4575

[73] Kawakami K, Mizumoto K, Ishihama A (1983). RNA polymerase of influenza virus. IV. Catalytic properties of the capped RNA endonuclease associated with the RNA polymerase. Nucleic Acids Res, 11(11): 3637–3649

[74] Kiso M, Shinya K, Shimojima M, Takano R, Takahashi K, Katsura H, Kakugawa S, Le M T, Yamashita M, Furuta Y, Ozawa M, Kawaoka Y (2010). Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses. PLoS Pathog, 6(8): e1001079

[75] Kobayashi M, Toyoda T, Ishihama A (1996). Influenza virus PB1 protein is the minimal and essential subunit of RNA polymerase. Arch Virol, 141(3-4): 525–539

[76] König R, Stertz S, Zhou Y, Inoue A, Hoffmann H H, Bhattacharyya S, Alamares J G, Tscherne D M, Ortigoza M B, Liang Y, Gao Q, Andrews S E, Bandyopadhyay S, De Jesus P, Tu B P, Pache L, Shih C, Orth A, Bonamy G, Miraglia L, Ideker T, García-Sastre A, Young J A, Palese P, Shaw M L, Chanda S K (2010). Human host factors required for influenza virus replication. Nature, 463(7282): 813–817

[77] Kormelink R, van Poelwijk F, Peters D, Goldbach R (1992). Non-viral heterogeneous sequences at the 5′ ends of tomato spotted wilt virus mRNAs. J Gen Virol, 73(8): 2125–2128

[78] Kuzuhara T, Kise D, Yoshida H, Horita T, Murazaki Y, Nishimura A, Echigo N, Utsunomiya H, Tsuge H(2009a). Structural basis of the influenza A virus RNA polymerase PB2 RNA-binding domain containing the pathogenicity-determinant lysine 627 residue. J Biol Chem, 284(22): 6855–6860

[79] Kuzuhara T, Kise D, Yoshida H, Horita T, Murazaki Y, Nishimura A, Echigo N, Utsunomiya H, Tsuge H (2009b). Structural basis of the influenza A virus RNA polymerase PB2 RNA-binding domain containing the pathogenicity-determinant lysine 627 residue. J Biol Chem, 284(11): 6855–6860

[80] Lackenby A, Thompson C I, Democratis J (2008). The potential impact of neuraminidase inhibitor resistant influenza. Curr Opin Infect Dis, 21(6): 626–638

[81] Leahy M B, Dobbyn H C, Brownlee G G (2001a). Hairpin loop structure in the 3′ arm of the influenza A virus virion RNA promoter is required for endonuclease activity. J Virol, 75(15): 7042–7049

[82] Leahy M B, Pritlove D C, Poon L L, Brownlee G G (2001b). Mutagenic analysis of the 5′ arm of the influenza A virus virion RNA promoter defines the sequence requirements for endonuclease activity. J Virol, 75(1): 134–142

[83] Li M L, Rao P, Krug R M (2001). The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits. EMBO J, 20(8): 2078–2086

[84] Li X, Palese P (1994). Characterization of the polyadenylation signal of influenza virus RNA. J Virol, 68(2): 1245–1249

[85] Li Z, Chen H, Jiao P, Deng G, Tian G, Li Y, Hoffmann E, Webster R G, Matsuoka Y, Yu K (2005). Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J Virol, 79(18): 12058–12064

[86] Luo G, Hamatake R K, Mathis D M, Racela J, Rigat K L, Lemm J, Colonno R J (2000). De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus. J Virol, 74(2): 851–863

[87] Luo G X, Luytjes W, Enami M, Palese P (1991). The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure. J Virol, 65(6): 2861–2867

[88] Mark G E, Taylor J M, Broni B, Krug R M (1979). Nuclear accumulation of influenza viral RNA transcripts and the effects of cycloheximide, actinomycin D, and alpha-amanitin. J Virol, 29(2): 744–752

[89] Martin K, Helenius A (1991). Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell, 67(1): 117–130

[90] Massin P, van der Werf S, Naffakh N (2001). Residue 627 of PB2 is a determinant of cold sensitivity in RNA replication of avian influenza viruses. J Virol, 75(11): 5398–5404

[91] Mayer D, Molawi K, Martínez-Sobrido L, Ghanem A, Thomas S, Baginsky S, Grossmann J, García-Sastre A, Schwemmle M (2007). Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches. J Proteome Res, 6(2): 672–682

[92] Mehle A, Doudna J A (2008). An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase. Cell Host Microbe, 4(2): 111–122

[93] Momose F, Basler C F, O’Neill R E, Iwamatsu A, Palese P, Nagata K (2001). Cellular splicing factor RAF-2p48/NPI-5/BAT1/UAP56 interacts with the influenza virus nucleoprotein and enhances viral RNA synthesis. J Virol, 75(4): 1899–1908

[94] Momose F, Handa H, Nagata K (1996). Identification of host factors that regulate the influenza virus RNA polymerase activity. Biochimie, 78(11-12): 1103–1108

[95] Momose F, Naito T, Yano K, Sugimoto S, Morikawa Y, Nagata K (2002). Identification of Hsp90 as a stimulatory host factor involved in influenza virus RNA synthesis. J Biol Chem, 277(47): 45306–45314

[96] Monsalvo A C, Batalle J P, Lopez M F, Krause J C, Klemenc J, Hernandez J Z, Maskin B, Bugna J, Rubinstein C, Aguilar L, Dalurzo L, Libster R, Savy V, Baumeister E, Aguilar L, Cabral G, Font J, Solari L, Weller K P, Johnson J, Echavarria M, Edwards K M, Chappell J D, Crowe J E Jr, Williams J V, Melendi G A, Polack F P (2011). Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat Med, 17(2): 195–199

[97] Moscona A (2009). Global transmission of oseltamivir-resistant influenza. N Engl J Med, 360(10): 953–956

[98] Moss R B, Davey R T, Steigbigel R T, Fang F (2010). Targeting pandemic influenza: a primer on influenza antivirals and drug resistance. J Antimicrob Chemother, 65(6): 1086–1093

[99] Nagata K, Kawaguchi A, Naito T (2008). Host factors for replication and transcription of the influenza virus genome. Rev Med Virol, 18(4): 247–260

[100] Naito T, Kiyasu Y, Sugiyama K, Kimura A, Nakano R, Matsukage A, Nagata K (2007a). An influenza virus replicon system in yeast identified Tat-SF1 as a stimulatory host factor for viral RNA synthesis. Proc Natl Acad Sci USA, 104(46): 18235–18240

[101] Naito T, Momose F, Kawaguchi A, Nagata K (2007b). Involvement of Hsp90 in assembly and nuclear import of influenza virus RNA polymerase subunits. J Virol, 81(3): 1339–1349

[102] Nakagawa Y, Oda K, Nakada S (1996). The PB1 subunit alone can catalyze cRNA synthesis, and the PA subunit in addition to the PB1 subunit is required for viral RNA synthesis in replication of the influenza virus genome. J Virol, 70(9): 6390–6394

[103] Neumann G, Castrucci M R, Kawaoka Y (1997). Nuclear import and export of influenza virus nucleoprotein. J Virol, 71(12): 9690–9700

[104] Neumann G, Hobom G (1995). Mutational analysis of influenza virus promoter elements in vivo. J Gen Virol, 76(7): 1709–1717

[105] Newcomb L L, Kuo R L, Ye Q, Jiang Y, Tao Y J, Krug R M (2009). Interaction of the influenza a virus nucleocapsid protein with the viral RNA polymerase potentiates unprimed viral RNA replication. J Virol, 83(1): 29–36

[106] O’Neill R E, Jaskunas R, Blobel G, Palese P, Moroianu J (1995). Nuclear import of influenza virus RNA can be mediated by viral nucleoprotein and transport factors required for protein import. J Biol Chem, 270(39): 22701–22704

[107] O’Neill R E, Palese P (1995). NPI-1, the human homolog of SRP-1, interacts with influenza virus nucleoprotein. Virology, 206(1): 116–125

[108] Obayashi E, Yoshida H, Kawai F, Shibayama N, Kawaguchi A, Nagata K, Tame J R, Park S Y (2008). The structural basis for an essential subunit interaction in influenza virus RNA polymerase. Nature, 454(7208): 1127–1131

[109] Oberg B (2006). Rational design of polymerase inhibitors as antiviral drugs. Antiviral Res, 71(2-3): 90–95

[110] Ohtsu Y, Honda Y, Sakata Y, Kato H, Toyoda T (2002). Fine mapping of the subunit binding sites of influenza virus RNA polymerase. Microbiol Immunol, 46(3): 167–175

[111] Ortega J, Martín-Benito J, Zürcher T, Valpuesta J M, Carrascosa J L, Ortín J (2000). Ultrastructural and functional analyses of recombinant influenza virus ribonucleoproteins suggest dimerization of nucleoprotein during virus amplification. J Virol, 74(1): 156–163

[112] Palese P, Shaw M L (2007). Orthomyxoviridae: the Viruses and Their Replication, 5th ed. Lippincott Williams & Wilkins

[113] Paul A V, Rieder E, Kim D W, van Boom J H, Wimmer E (2000). Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg. J Virol, 74(22): 10359–10370

[114] Pérez D R, Donis R O (1995). A 48-amino-acid region of influenza A virus PB1 protein is sufficient for complex formation with PA. J Virol, 69(11): 6932–6939

[115] Pérez-González A, Rodriguez A, Huarte M, Salanueva I J, Nieto A (2006). hCLE/CGI-99, a human protein that interacts with the influenza virus polymerase, is a mRNA transcription modulator. J Mol Biol, 362(5): 887–900

[116] Plotch S J, Bouloy M, Ulmanen I, Krug R M (1981). A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell, 23(3): 847–858

[117] Plotch S J, Krug R M (1977). Influenza virion transcriptase: synthesis in vitro of large, polyadenylic acid-containing complementary RNA. J Virol, 21(1): 24–34

[118] Plotch S J, Krug R M (1978). Segments of influenza virus complementary RNA synthesized in vitro. J Virol, 25(2): 579–586

[119] Plotkin J B, Dushoff J, Levin S A (2002). Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus. Proc Natl Acad Sci USA, 99(9): 6263–6268

[120] Poole E L, Medcalf L, Elton D, Digard P (2007). Evidence that the C-terminal PB2-binding region of the influenza A virus PB1 protein is a discrete α-helical domain. FEBS Lett, 581(27): 5300–5306

[121] Poon L L, Fodor E, Brownlee G G (2000). Polyuridylated mRNA synthesized by a recombinant influenza virus is defective in nuclear export. J Virol, 74(1): 418–427

[122] Poon L L, Pritlove D C, Fodor E, Brownlee G G (1999). Direct evidence that the poly(A) tail of influenza A virus mRNA is synthesized by reiterative copying of a U track in the virion RNA template. J Virol, 73(4): 3473–3476

[123] Poon L L, Pritlove D C, Sharps J, Brownlee G G (1998). The RNA polymerase of influenza virus, bound to the 5′ end of virion RNA, acts in cis to polyadenylate mRNA. J Virol, 72(10): 8214–8219

[124] Pritlove D C, Poon L L, Devenish L J, Leahy M B, Brownlee G G (1999). A hairpin loop at the 5′ end of influenza A virus virion RNA is required for synthesis of poly(A)+ mRNA in vitro. J Virol, 73(3): 2109–2114

[125] Pritlove D C, Poon L L, Fodor E, Sharps J, Brownlee G G (1998). Polyadenylation of influenza virus mRNA transcribed in vitro from model virion RNA templates: requirement for 5′ conserved sequences. J Virol, 72(2): 1280–1286

[126] Rao P, Yuan W, Krug R M (2003). Crucial role of CA cleavage sites in the cap-snatching mechanism for initiating viral mRNA synthesis. EMBO J, 22(5): 1188–1198

[127] Resa-Infante P, Jorba N, Zamarreño N, Fernández Y, Juárez S, Ortín J (2008). The host-dependent interaction of alpha-importins with influenza PB2 polymerase subunit is required for virus RNA replication. PLoS ONE, 3(12): e3904

[128] Robertson J S, Schubert M, Lazzarini R A (1981). Polyadenylation sites for influenza virus mRNA. J Virol, 38(1): 157–163

[129] Seong B L, Kobayashi M, Nagata K, Brownlee G G, Ishihama A (1992). Comparison of two reconstituted systems for in vitro transcription and replication of influenza virus. J Biochem, 111(4): 496–499

[130] Shapiro G I, Krug R M (1988). Influenza virus RNA replication in vitro: synthesis of viral template RNAs and virion RNAs in the absence of an added primer. J Virol, 62(7): 2285–2290

[131] Shaw M W, Lamb R A (1984). A specific sub-set of host-cell mRNAs prime influenza virus mRNA synthesis. Virus Res, 1(6): 455–467

[132] Su C Y, Cheng T J, Lin M I, Wang S Y, Huang W I, Lin-Chu S Y, Chen Y H, Wu C Y, Lai M M, Cheng W C, Wu Y T, Tsai M D, Cheng Y S, Wong C H (2010). High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity. Proc Natl Acad Sci USA, 107(45): 19151–19156

[133] Subbarao E K, London W, Murphy B R (1993). A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J Virol, 67(4): 1761–1764

[134] Sugiyama K, Obayashi E, Kawaguchi A, Suzuki Y, Tame J R, Nagata K, Park S Y (2009). Structural insight into the essential PB1-PB2 subunit contact of the influenza virus RNA polymerase. EMBO J, 28(12): 1803–1811

[135] Tarendeau F, Boudet J, Guilligay D, Mas P J, Bougault C M, Boulo S, Baudin F, Ruigrok R W, Daigle N, Ellenberg J, Cusack S, Simorre J P, Hart D J (2007). Structure and nuclear import function of the C-terminal domain of influenza virus polymerase PB2 subunit. Nat Struct Mol Biol, 14(3): 229–233

[136] Testa D, Banerjee A K (1979). Initiation of RNA synthesis in vitro by vesicular stomatitis virus. Role of ATP. J Biol Chem, 254(6): 2053–2058

[137] Torreira E, Schoehn G, Fernández Y, Jorba N, Ruigrok R W, Cusack S, Ortín J, Llorca O (2007). Three-dimensional model for the isolated recombinant influenza virus polymerase heterotrimer. Nucleic Acids Res, 35(11): 3774–3783

[138] Toyoda T, Adyshev D M, Kobayashi M, Iwata A, Ishihama A (1996a). Molecular assembly of the influenza virus RNA polymerase: determination of the subunit-subunit contact sites. J Gen Virol, 77(9): 2149–2157

[139] Toyoda T, Kobayashi M, Nakada S, Ishihama A (1996b). Molecular dissection of influenza virus RNA polymerase: PB1 subunit alone is able to catalyze RNA synthesis. Virus Genes, 12(2): 155–163

[140] Tsai C H, Lee P Y, Stollar V, Li M L (2006). Antiviral therapy targeting viral polymerase. Curr Pharm Des, 12(11): 1339–1355

[141] Ulmanen I, Broni B, Krug R M (1983). Influenza virus temperature-sensitive cap (m7GpppNm)-dependent endonuclease. J Virol, 45(1): 27–35

[142] Ulmanen I, Broni B A, Krug R M (1981). Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription. Proc Natl Acad Sci USA, 78(12): 7355–7359

[143] van Dijk A A, Makeyev E V, Bamford D H (2004). Initiation of viral RNA-dependent RNA polymerization. J Gen Virol, 85(5): 1077–1093

[144] Vreede F T, Brownlee G G (2007). Influenza virion-derived viral ribonucleoproteins synthesize both mRNA and cRNA in vitro. J Virol, 81(5): 2196–2204

[145] Vreede F T, Gifford H, Brownlee G G (2008). Role of initiating nucleoside triphosphate concentrations in the regulation of influenza virus replication and transcription. J Virol, 82(14): 6902–6910

[146] Vreede F T, Jung T E, Brownlee G G (2004). Model suggesting that replication of influenza virus is regulated by stabilization of replicative intermediates. J Virol, 78(17): 9568–9572

[147] Wang P, Palese P, O’Neill R E (1997). The NPI-1/NPI-3 (karyopherin alpha) binding site on the influenza a virus nucleoprotein NP is a nonconventional nuclear localization signal. J Virol, 71(3): 1850–1856

[148] Watanabe K, Handa H, Mizumoto K, Nagata K (1996). Mechanism for inhibition of influenza virus RNA polymerase activity by matrix protein. J Virol, 70(1): 241–247

[149] Weber F, Kochs G, Gruber S, Haller O (1998). A classical bipartite nuclear localization signal on Thogoto and influenza A virus nucleoproteins. Virology, 250(1): 9–18

[150] Webster R G, Sharp G B, Claas E C (1995). Interspecies transmission of influenza viruses. Am J Respir Crit Care Med, 152(4 Pt 2): S25–S30

[151] Wright P F, Neumann G, Kawaoka Y (2007). Orthomyxoviruses, 5th ed. Lippincott Williams & Wilkins.

[152] Yang Y, Rijnbrand R, Watowich S, Lemon S M (2004). Genetic evidence for an interaction between a picornaviral cis-acting RNA replication element and 3CD protein. J Biol Chem, 279(13): 12659–12667

[153] Ye Q, Krug R M, Tao Y J (2006). The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Nature, 444(7122): 1078–1082

[154] Ye Z P, Pal R, Fox J W, Wagner R R (1987). Functional and antigenic domains of the matrix (M1) protein of influenza A virus. J Virol, 61(2): 239–246

[155] Yuan P, Bartlam M, Lou Z, Chen S, Zhou J, He X, Lv Z, Ge R, Li X, Deng T, Fodor E, Rao Z, Liu Y (2009). Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site. Nature, 458(7240): 909–913

[156] Zhang S, Wang J, Wang Q, Toyoda T (2010a). Internal initiation of influenza virus replication of viral RNA and complementary RNA in vitro. J Biol Chem, 285: 41194–41201

[157] Zhang S, Weng L, Geng L, Wang J, Zhou J, Deubel V, Buchy P, Toyoda T (2010b). Biochemical and kinetic analysis of the influenza virus RNA polymerase purified from insect cells. Biochem Biophys Res Commun, 391(1): 570–574

[158] Zhao C, Lou Z, Guo Y, Ma M, Chen Y, Liang S, Zhang L, Chen S, Li X, Liu Y, Bartlam M, Rao Z (2009). Nucleoside monophosphate complex structures of the endonuclease domain from the influenza virus polymerase PA subunit reveal the substrate binding site inside the catalytic center. J Virol, 83(18): 9024–9030

[159] Zheng H, Lee H A, Palese P, García-Sastre A (1999). Influenza A virus RNA polymerase has the ability to stutter at the polyadenylation site of a viral RNA template during RNA replication. J Virol, 73(6): 5240–5243

[160] Zvonarjev A Y, Ghendon Y Z (1980). Influence of membrane (M) protein on influenza A virus virion transcriptase activity in vitro and its susceptibility to rimantadine. J Virol, 33(2): 583–586

RIGHTS & PERMISSIONS

2014 Higher Education Press and Springer-Verlag Berlin Heidelberg